Cellebrite
CLBT
94 hedge funds and large institutions have $427M invested in Cellebrite in 2023 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 46 increasing their positions, 16 reducing their positions, and 6 closing their positions.
267% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 6
188% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 16
167% more call options, than puts
Call options by funds: $786K | Put options by funds: $294K
40% more funds holding in top 10
Funds holding in top 10: 5 → 7 (+2)
40% more capital invested
Capital invested by funds: $305M → $427M (+$122M)
21% more funds holding
Funds holding: 78 → 94 (+16)
6.84% more ownership
Funds ownership: 21.78% → 28.61% (+6.8%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CI
Clal Insurance
Tel-Aviv,
Israel
|
+$49.3M |
| 2 |
MCM
Makena Capital Management
Menlo Park,
California
|
+$18.8M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$9.23M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$6.63M |
| 5 |
Millennium Management
New York
|
+$5.98M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NRCM
Northern Right Capital Management
Darien,
Connecticut
|
-$8.88M |
| 2 |
IP
Isomer Partners
New York
|
-$4.02M |
| 3 |
KLC
Kent Lake Capital
Reno,
Nevada
|
-$2.77M |
| 4 |
GRIM
Greenhaven Road Investment Management
Greenwich,
Connecticut
|
-$2.68M |
| 5 |
PF
Phoenix Financial
Givatayim,
Israel
|
-$2.46M |
CLBT Hedge Fund Activity: Q3 2023 in Review
94 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Cellebrite (CLBT) for Q3 2023, worth a combined $427M — up 40% from $305M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new CLBT positions and 6 closed out — a net gain of 16 holders — while 46 added to existing stakes and 16 trimmed.
The largest buyer was Clal Insurance, opening a new position worth an estimated $49.3M. The largest seller was Northern Right Capital Management, exiting entirely with an estimated $8.88M sold.
- 94 institutional investors held Cellebrite (CLBT) as of Q3 2023, up from 78 in Q2 2023.
- Funds reported $427M of Cellebrite stock for Q3 2023, up 40% quarter-over-quarter.
- 22 funds opened new Cellebrite positions in Q3 2023 and 6 closed out, a net change of +16 holders.
- The largest Cellebrite buyer in Q3 2023 was Clal Insurance, an estimated $49.3M added.
- The largest Cellebrite seller in Q3 2023 was Northern Right Capital Management, an estimated $8.88M sold.
Based on aggregated 13F filings for Q3 2023.